Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Cash & Current Investments (2016 - 2025)

Standard Biotools (LAB) has disclosed Cash & Current Investments for 16 consecutive years, with $187.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 35.95% to $187.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $187.6 million through Dec 2025, down 35.95% year-over-year, with the annual reading at $187.6 million for FY2025, 35.95% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $187.6 million at Standard Biotools, down from $194.9 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $463.6 million in Q1 2024, with the low at $29.5 million in Q4 2021.
  • Average Cash & Current Investments over 5 years is $184.0 million, with a median of $176.5 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments tumbled 58.66% in 2021, then skyrocketed 565.73% in 2022.
  • Over 5 years, Cash & Current Investments stood at $29.5 million in 2021, then soared by 466.05% to $166.8 million in 2022, then plummeted by 30.64% to $115.7 million in 2023, then soared by 153.15% to $292.9 million in 2024, then crashed by 35.95% to $187.6 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $187.6 million, $194.9 million, and $237.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.